Open AccessSingle-dose methotrexate for the treatment of ectopic pregnancy: Our experience from 2010 to 2015
Author(s) -
Emre Erdem Taş,
Gülin Feykan Feykan Yeğin Akçay,
Ayşe Filiz Avşar
Publication year - 2017
Publication title -
pakistan journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.316
H-Index - 30
eISSN - 1682-024X
pISSN - 1681-715X
DOI - 10.12669/pjms.331.11238
Subject(s) - medicine , methotrexate , human chorionic gonadotropin , ectopic pregnancy , retrospective cohort study , cutoff , pregnancy , gastroenterology , odds ratio , urology , vaginal bleeding , obstetrics , gynecology , hormone , physics , quantum mechanics , biology , genetics
To evaluate the success of systemic single-dose methotrexate (MTX) treatment in patients with ectopic pregnancy (EP) and to investigate factors related to treatment success.